BridgeMD
New treatment option for Respiratory Syncytial Virus (RSV)
Official title Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age
ClinicalTrials.gov ID: NCT07516418
What this study is testing
What is H5 Flu Investigational Medical Product (IMP) 1?
H5 Flu Investigational Medical Product (IMP) 1 is an investigational medicine, given as an injection into a muscle, being studied as a potential treatment for respiratory syncytial virus (rsv).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to evaluate the safety and immunogenicity of different formulations of vaccines encoding the RSV monovalent antigen or the Flu hemagglutinin subtype 5 (H5) antigen in healthy participants aged 18 to 49 years. The total duration of study participation for each participant varies by stage and treatment arm.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 49. Healthy volunteers may be eligible.
You may be able to join if
- Aged 18 to 49 years on the day of inclusion
- A female participant is eligible to participate if she is not pregnant or breastfeeding and of the following conditions applies:
- Is of NCBP (Non-Child-Bearing Potential). To be considered of NCBP, a female must be post-menopausal for at least 1 year, or surgically sterile. OR
- Is of CBP (Child-Bearing Potential) and uses an effective contraceptive method or abstinence from at least 4 weeks prior to study intervention...
You likely can't join if
- Any condition which, in the opinion of the Investigator, might interfere with the evaluation of the study objectives
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
The study team makes the final eligibility decision.
Where it's taking place
- Griffith, Queensland, Australia
- Herston, Queensland, Australia
- Morayfield, Queensland, Australia
- Sippy Downs, Queensland, Australia
- South Brisbane, Queensland, Australia
- Taringa, Queensland, Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 49 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Griffith, Queensland, Australia; Herston, Queensland, Australia; Morayfield, Queensland, Australia; Sippy Downs, Queensland, Australia; South Brisbane, Queensland, Australia; Taringa, Queensland, Australia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.